English | Español

Csl Behring
Carol Ostrow | Dec 16, 2017

CSL partners with Vitaeris for organ transplant therapy
Carol Ostrow | Sep 29, 2017

CSL Behring pledges $4.92 million for Penn State biotechnology center
Erianne Leatherman | Apr 18, 2017

CSL Behring honors World Hemophilia Day with medications donation
Erianne Leatherman | Apr 14, 2017

CSL Behring awards grants to four groups to boost support for patients with rare diseases
Erianne Leatherman | Apr 12, 2017

CSL Behring to sponsor Jeffrey Modell North African Network for primary immunodeficiency
Jeff Gantt | Dec 18, 2016

Afstyla approved by Health Canada
Amanda Rupp | Jun 22, 2016

CSL Behring honors 2016 HAE Day with events
Amanda Rupp | Jun 1, 2016

Afstyla gains FDA approval as hemophilia A treatment

Trending
+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas
Patient Daily | Jul 25, 2025

Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval